
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.630 | 3.630 | 0.000 |
Shares | 96.370 | 96.370 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.693 | 17.587 |
Price to Book | 2.425 | 2.648 |
Price to Sales | 0.932 | 1.981 |
Price to Cash Flow | 9.318 | 11.268 |
Dividend Yield | 2.398 | 2.179 |
5 Years Earnings Growth | 7.954 | 10.902 |
Name | Net % | Category Average |
---|---|---|
Consumer Defensive | 41.280 | 7.976 |
Healthcare | 36.800 | 13.078 |
Communication Services | 8.880 | 6.790 |
Utilities | 8.580 | 3.492 |
Consumer Cyclical | 2.940 | 10.548 |
Basic Materials | 1.520 | 7.458 |
Number of long holdings: 53
Number of short holdings: 10
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Cencora Inc | US03073E1055 | 3.26 | 291.61 | +0.59% | |
Iberdrola | ES0144580Y14 | 3.23 | 16.075 | -0.68% | |
Mondelez | US6092071058 | 3.18 | 61.44 | +0.26% | |
PepsiCo | US7134481081 | 3.15 | 148.65 | +1.14% | |
L'Oreal | FR0000120321 | 3.07 | 397.90 | -1.11% | |
Viscofan | ES0184262212 | 2.83 | 59.800 | +0.17% | |
Ahold Delhaize | NL0011794037 | 2.81 | 34.25 | 0.00% | |
Orange | FR0000133308 | 2.73 | 13.90 | +1.24% | |
Novartis | CH0012005267 | 2.48 | 101.16 | -0.37% | |
Galenica Sante | CH0360674466 | 2.44 | 85.70 | +0.06% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ACATIS Fair Value Modulor Vermogens | 275.23M | 0.02 | -2.02 | 4.52 | ||
ACATIS Fair Value Modulor Vermogeni | 275.23M | -0.37 | -2.67 | 3.93 | ||
FU Fonds Multi Asset Fonds P | 100.14M | -2.01 | 6.17 | 6.46 | ||
H A Aktien Small Cap EMU A | 87.61M | 15.99 | 8.78 | 6.98 | ||
H A Aktien Small Cap EMU C I | 87.61M | 16.37 | 9.39 | 7.55 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review